← Open Payments lookup

PAMELA ALFAFARA: Open Payments

NPI 1558387985 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,099 in 42 payments from 14 companies in 2025. Trend: 2023 $1,298 · 2024 $1,021 · 2025 $1,099

Food & beverage: $1,099
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.7$175
Neurocrine BioSciences, Inc.6$157
Teva Pharmaceuticals USA, Inc.4$125
Lundbeck LLC4$114
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$113
Janssen Pharmaceuticals, Inc3$82
Axsome Therapeutics, Inc.2$65
Biogen, Inc.2$60
Collegium Pharmaceutical, Inc.2$49
ABBVIE INC.3$46

Products named: COBENFY, INGREZZA, REXULTI, AUSTEDO XR, CAPLYTA, Auvelity, ZURZUVAE, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.